By otakuyassine3@gmail.com 
Bank of America started coverage on shares of Surgery Partners (NASDAQ:SGRY – Free Report) in a research report released on Monday, MarketBeat Ratings reports. The firm issued a buy rating and a $30.00 price target on the stock.
Other research analysts have also recently issued reports about the company. JPMorgan Chase & Co. lowered their price objective on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research report on Friday, October 4th. KeyCorp began coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. UBS Group started coverage on shares of Surgery Partners in a report on Monday, October 14th. They issued a “buy” rating and a $38.00 target price for the company. Finally, Macquarie reissued an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $36.56.
Get Our Latest Stock Analysis on SGRY
Surgery Partners Price Performance
NASDAQ SGRY opened at $19.88 on Monday. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. Surgery Partners has a 1-year low of $19.83 and a 1-year high of $35.29. The stock has a market capitalization of $2.53 billion, a price-to-earnings ratio of -41.42, a PEG ratio of 17.40 and a beta of 2.58. The business’s fifty day moving average price is $26.59 and its 200-day moving average price is $27.89.
Surgery Partners (NASDAQ:SGRY – Get Free Report) last announced its earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. During the same period in the previous year, the business posted $0.15 earnings per share. The company’s revenue for the quarter was up 14.3% on a year-over-year basis. On average, equities analysts predict that Surgery Partners will post 0.71 earnings per share for the current year.
Institutional Investors Weigh In On Surgery Partners
Institutional investors and hedge funds have recently modified their holdings of the business. Franklin Resources Inc. grew its stake in Surgery Partners by 19.5% in the 3rd quarter. Franklin Resources Inc. now owns 21,324 shares of the company’s stock worth $677,000 after acquiring an additional 3,487 shares in the last quarter. Sanctuary Advisors LLC purchased a new position in Surgery Partners during the 3rd quarter worth $626,000. King Street Capital Management L.P. bought a new stake in Surgery Partners during the 3rd quarter valued at $46,748,000. Geode Capital Management LLC lifted its holdings in shares of Surgery Partners by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,864,346 shares of the company’s stock worth $60,117,000 after buying an additional 42,897 shares during the period. Finally, MidWestOne Financial Group Inc. lifted its holdings in shares of Surgery Partners by 3.8% in the 3rd quarter. MidWestOne Financial Group Inc. now owns 73,502 shares of the company’s stock worth $2,370,000 after buying an additional 2,716 shares during the period.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Articles
Receive News & Ratings for Surgery Partners Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Surgery Partners and related companies with MarketBeat.com’s FREE daily email newsletter.